These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6723122)

  • 21. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of D-penicillamine on plasma amino acids in rheumatoid arthritis.
    Partsch G; Tausch G; Neuwirth E; Neumüller J
    Z Rheumatol; 1983; 42(3):126-9. PubMed ID: 6880413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of analytical approaches to the measurement of D-penicillamine and penicillamine disulfides.
    Lecavalier DR; Crawhall JC
    J Rheumatol Suppl; 1981; 7():20-27. PubMed ID: 7014874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes].
    Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV
    Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Zinc levels in blood and urine of rheumatoid arthritis patients after four months treatment with D-penicillamine].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Z Rheumatol; 1980; 39(11-12):395-400. PubMed ID: 7282103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W; Keitel W
    Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of penicillamine on the blood serum copper level and acute phase tests in patients with rheumatoid arthritis].
    Rudy J; Sarosiek J
    Reumatologia; 1978; 16(2):237-44. PubMed ID: 694258
    [No Abstract]   [Full Text] [Related]  

  • 29. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lichenoid lesions of the oral mucosa in rheumatoid arthritis patients treated with penicillamine.
    Blasberg B; Dorey JL; Stein HB; Chalmers A; Conklin RJ
    J Rheumatol; 1984 Jun; 11(3):348-51. PubMed ID: 6737375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acadione, a new long-term treatment of rheumatoid polyarthritis].
    Amor B; Mery C; de Gery A
    Rev Rhum Mal Osteoartic; 1988 Apr; 55(6):462-6. PubMed ID: 3393845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U; Bussmann HU; Jerusalem F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
    Slatter JG; Stalker DJ; Feenstra KL; Welshman IR; Bruss JB; Sams JP; Johnson MG; Sanders PE; Hauer MJ; Fagerness PE; Stryd RP; Peng GW; Shobe EM
    Drug Metab Dispos; 2001 Aug; 29(8):1136-45. PubMed ID: 11454733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugs.
    Dixon JS; Bird HA; Martin MF; McKenna F; Wright V
    Int J Clin Pharmacol Res; 1985; 5(1):25-33. PubMed ID: 2860075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The serum copper level and the therapeutic effect of D-penicylamine in patients with rheumatoid arthritis (author's transl)].
    Rudy J; Sarosiek J; Borejszo I
    Przegl Lek; 1978; 35(12):879-83. PubMed ID: 734155
    [No Abstract]   [Full Text] [Related]  

  • 36. [Our 1st experiences with the use of D-penicillamine in the treatment of rheumatoid arthritis].
    Pucar I; Dürrigl T
    Lijec Vjesn; 1974 Mar; 96(5):300-4. PubMed ID: 4469807
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of D-penicillamine on zinc levels in blood and urine of patients with chronic polyarthritis].
    Tausch G; Teherani DK; Bröll H; Eberl R; Altmann H
    Z Rheumatol; 1978; 37(5-6):148-52. PubMed ID: 685511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of Cuprenil (D-penicillamine) treatment in patients with rheumatoid arthritis].
    Maldykowa H; Chwalińska-Sadowska H; Luft S; Glińska-Urban D; Mikolajew M; Odrzywolska A; Jaworska H
    Reumatologia; 1972; 10(1):9-21. PubMed ID: 5019762
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tiopronine: new basic treatment for rheumatoid arthritis. Open study of 158 cases].
    Pasero G; Pellegrini P; Ciompi ML; Colamussi V; Barbieri P; Mazzoni MR
    Rev Rhum Mal Osteoartic; 1980 Mar; 47(3):163-8. PubMed ID: 7384725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.